CA3091186C - Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs - Google Patents

Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs Download PDF

Info

Publication number
CA3091186C
CA3091186C CA3091186A CA3091186A CA3091186C CA 3091186 C CA3091186 C CA 3091186C CA 3091186 A CA3091186 A CA 3091186A CA 3091186 A CA3091186 A CA 3091186A CA 3091186 C CA3091186 C CA 3091186C
Authority
CA
Canada
Prior art keywords
amount
oil
composition
emulsion
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3091186A
Other languages
English (en)
Other versions
CA3091186A1 (fr
Inventor
Elham Rahmani Neishaboor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Nano Pharmaceutical Technology Inc
Original Assignee
Canadian Nano Pharmaceutical Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Nano Pharmaceutical Technology Inc filed Critical Canadian Nano Pharmaceutical Technology Inc
Priority to CA3091186A priority Critical patent/CA3091186C/fr
Publication of CA3091186A1 publication Critical patent/CA3091186A1/fr
Application granted granted Critical
Publication of CA3091186C publication Critical patent/CA3091186C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Il est décrit des compositions qui consistent en une nano-émulsion dhuile et deau propagée dans une phase huileuse externe, des modes de préparation de ces compositions ainsi que des modes dutilisation de ces compositions, comme la libération dingrédients actifs dans un sujet. Les méthodes comprennent la combinaison dun premier mélange composé dune huile à létat liquide et dun lipide chargé à un deuxième mélange aqueux constitué dun émulsifiant thermoréversible qui forme un film en vue de préparer une nano-émulsion dhuile et deau, suivie par la combinaison de la nano-émulsion dhuile et deau à un troisième mélange composé dune combinaison de lipides à létat solide en vue de préparer la composition.
CA3091186A 2020-08-26 2020-08-26 Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs Active CA3091186C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3091186A CA3091186C (fr) 2020-08-26 2020-08-26 Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3091186A CA3091186C (fr) 2020-08-26 2020-08-26 Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs

Publications (2)

Publication Number Publication Date
CA3091186A1 CA3091186A1 (fr) 2020-10-26
CA3091186C true CA3091186C (fr) 2022-02-08

Family

ID=73034355

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3091186A Active CA3091186C (fr) 2020-08-26 2020-08-26 Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs

Country Status (1)

Country Link
CA (1) CA3091186C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024254228A1 (fr) * 2023-06-06 2024-12-12 LifeActive, Inc. Formulations pour administration transdermique

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4112042B1 (fr) * 2021-06-30 2026-02-18 Haleon CH SARL Nanoémulsion comprenant du diclofénac
CN114681351A (zh) * 2022-04-01 2022-07-01 广州市娇兰化妆品有限公司 一种具有三重作用的类神经酰胺提取物的纳米乳液及其制备方法与应用
WO2025062440A1 (fr) * 2023-09-20 2025-03-27 Pulse Pharmaceuticals Pvt. Ltd Compositions topiques de nano-dispersion et leur préparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024254228A1 (fr) * 2023-06-06 2024-12-12 LifeActive, Inc. Formulations pour administration transdermique

Also Published As

Publication number Publication date
CA3091186A1 (fr) 2020-10-26

Similar Documents

Publication Publication Date Title
CA3091186C (fr) Compositions a base de nanoemulsions, procedes de leur preparation et leur utilisation dans la livraison d`ingredients actifs
US11517546B2 (en) High concentration local anesthetic formulations
US20220152039A1 (en) Transdermal delivery of diclofenac, carbamazepine and benzydamine
Tamarkin Foam: a unique delivery vehicle for topically applied formulations
CA2696632C (fr) Formulations anesthesiques locales a concentration elevee
US20060211688A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
JP4549006B2 (ja) ゲル軟膏
AU2018273410A1 (en) Biphasix cannabinoid delivery
WO2020220141A1 (fr) Formulations transdermiques de stock de cannabinoïdes
BR112020014252A2 (pt) formulações de canabinóides encapsuladas para distribuição transdérmica
AU2008309170A1 (en) A non-aqueous topical solution of diclofenac and process for preparing the same
JP5052558B2 (ja) ゲル軟膏
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
US12324854B2 (en) Nano-emulsion based compositions, methods for their preparation and their use in delivery of active ingredients
EP1858556A1 (fr) Vehicule pour administration topique de composes anti-inflammatoires
Campbell et al. A review of the clinical indications, general principles and techniques related to compounding
CA2500907A1 (fr) Vehicule d'administration topique de composes anti-inflammatoires
Arianto et al. The effect of tween 80, palm kernel oil, and its conversion product on in vitro penetration enhancement of indomethacin through rabbit skin
JP2025531334A (ja) 水アルコール局所ジクロフェナク製剤
Bagul et al. Emulgel-A Novel Advance for Skin Disease
WO2022140467A1 (fr) Compositions topiques et procédés de traitement de maladies et d'états cutanés avec de telles compositions
JP2025531333A (ja) ジクロフェナクの局所送達のための水アルコール単相ゲル組成物
Jariwala et al. EMULGEL: AN EMERGING NOVEL DRUG DELIVERY SYSTEM

Legal Events

Date Code Title Description
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240823

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240823

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250626

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250626